72 software-engineering-model-driven-engineering-phd-position Postdoctoral positions at Duke University
Sort by
Refine Your Search
-
the molecular and cellular mechanisms of vision and retinal disease. This position offers an exciting opportunity to contribute to innovative research focused on the development and maintenance of the light
-
-edge technologies, including genetically engineered mouse models, patient-derived models, single-cell and spatial genomics, organoid systems, and preclinical therapeutic studies. Learn more about our
-
. or equivalent doctorate (e.g. Sc.D., M.D., D.V.M.) Preferred Qualifications:. A PhD or MD/PhD (or equivalent) in biological sciences Strong research background in cell biology, molecular biology, mouse models
-
-epithelial interactions. The role employs a multi-modal research approach spanning genetically engineered mouse models, histopathology, mouse and human organoids, CRISPR-Cas9 gene editing, single-cell
-
Position Description Duke University was created in 1924 through an indenture of trust by James Buchanan Duke. Today, Duke is regarded as one of America’s leading research universities. Located in
-
software. Receive tailored mentorship in grant writing (e.g., NIH K99/R00), career planning, and leadership. Minimum Qualifications: The candidate should hold a PhD (or equivalent) in Computer Science
-
. Postdoctoral Associate Positions in Regeneration Genomics Diao Lab, Duke University School of Medicine The Diao Lab in the Department of Cell Biology at Duke University School of Medicine has multiple openings
-
the tumorigenicity of WT, D16, and p95 HER2 and using these models to test whether HER2 ICD- and p95 HER2-based vaccines generated by the laboratory prevent isoform-driven tumor formation Histological and molecular
-
Lab - Duke Human Vaccine Institute Be You. Position Overview: The Duke Human Vaccine Institute (DHVI) continues to lead cutting edge vaccine research against infectious diseases that impact global
-
. You will be co-mentored by Dr. Jason Somarelli, a PhD basic scientist, Dr. Andrew Armstrong, an MD medical oncologist. Minimum Requirements: PhD degree with a background in cancer immunology, prostate